PT Indicates Bullishness: FedEx, Apple, Amedisys, Cryoport, RenaissanceRe and Booking Holdings
- June 06th, 2023
- 613 views
FedEx Corporation (NYSE: FDX), a global leader in transportation and logistics services, has received an initiation of coverage from Atlantic Equities with an Overweight rating and a price target of $265.
Based on Tuesday's closing price of $219.50, this price target suggests a potential upside of $45.50 or 20.72% for $FDX, according to Atlantic Equities' analysis.
Apple Inc. (Nasdaq: AAPL), a renowned technology company known for its innovative products, has witnessed a price target increase from Wells Fargo, raising it from $185 to $210.
With $AAPL closing at $179.21 on Tuesday, this adjusted price target indicates a potential upside of $30.79 or 17.17%, as per Wells Fargo's view.
Amedisys, Inc. (Nasdaq: AMED), a leading provider of home health and hospice care, has seen its price target raised from $91 to $100 by Cantor Fitzgerald.
With a closing price of $92.37 on Tuesday, this revised price target suggests a potential upside of $7.63 or 8.26% for $AMED, based on Cantor Fitzgerald's assessment.
Cryoport, Inc. (Nasdaq: CYRX), a company specializing in temperature-controlled logistics solutions, has experienced a price target increase from UBS, raising it from $26 to $28.
Considering Tuesday's closing price of $21.57, this adjusted price target implies a potential upside of $6.43 or 29.84% for $CYRX, according to UBS' analysis.
RenaissanceRe Holdings Ltd. (NYSE: RNR), a global provider of reinsurance and insurance products, has received a price target increase from Wells Fargo, raising it from $257 to $260.
With $RNR closing at $193.15 on Tuesday, this adjusted price target suggests a potential upside of $66.85 or 34.63%, based on Wells Fargo's perspective.
Booking Holdings Inc. (Nasdaq: BKNG), a prominent online travel company, has been initiated with an Outperform rating by Wedbush, along with a price target of $3,060.
With Tuesday's closing price of $2,708.10, this price target indicates a potential upside of $351.90 or 13.00% for $BKNG, based on Wedbush's analysis.
Please note that the potential upside mentioned for each company is based on the respective brokerage firm, investment firm, or analysts' view. Investors should conduct their own research and consider other factors before making any investment decisions.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025Earnings Preview: Credo Technology, MongoDB, and Hafnia in Focus
November 30th, 2025




Member Login